955027-73-3

Basic information

• Product Name: cis-4-aMino-3-(Methoxy)te...
• Synonyms: cis-4-aMino-3-(Methoxy)te...;cis-4-aMino-3-(Methoxy)tetrahydropyran;cis-3-Methoxytetrahydro-2H-pyran-4-amine
• CAS NO: 955027-73-3
• Molecular Formula: C6H13NO2
• Molecular Weight: 131.18
• Mol File: 955027-73-3.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: cis-4-aMino-3-(Methoxy)te...(CAS DataBase Reference)
• NIST Chemistry Reference: cis-4-aMino-3-(Methoxy)te...(955027-73-3)
• EPA Substance Registry System: cis-4-aMino-3-(Methoxy)te...(955027-73-3)

Safety Data

• Hazardous Substances Data: 955027-73-3(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Synthesis:
cis-4-aMino-3-(Methoxy)te... is used as a key intermediate in the synthesis of various pharmaceuticals, contributing to the development of new medicinal drugs. Its unique structure allows for versatile chemical modifications, facilitating the creation of diverse drug candidates with potential therapeutic applications.
Used in Organic Chemistry Research:
In the field of organic chemistry, cis-4-aMino-3-(Methoxy)te... serves as an important molecule for studying the properties and reactions of tetrahydrofuran ring systems. Its cis-configuration and functional groups enable researchers to explore novel synthetic pathways and investigate the compound's reactivity, stability, and potential applications in organic synthesis.
Used in Medicinal Drug Development:
Due to its potential biological activity, cis-4-aMino-3-(Methoxy)te... is employed in the development of medicinal drugs. Its unique structure and properties make it a promising candidate for the design of new therapeutic agents, particularly in the areas of pharmaceuticals where novel compounds with specific biological activities are in high demand.

Upstream product

• 104681-92-7 4,4-dimethoxytetrahydro-2H-pyran-3-ol 
• 1232064-59-3 (3S,4S)-3-methoxy-N-((S)-1-phenylethyl)tetrahydro-2H-pyran-4-amine 
• 624734-17-4 3-methoxydihydro-2H-pyran-4(3H)-one 
• 1232060-82-0 C₁₄H₂₁NO₂ 

Relevant articles and documents

CHEMOKING RECEPTOR ANTAGONISTS

Disclosed herein are chemokine receptor antagonists of formula (I) wherein G1, X1, X2, and X3 are as defined in the specification. Compositions comprising such compounds; and methods for treating conditions and disorders using such compounds and compositions are also described.

NEW CCR2 RECEPTOR ANTAGONISTS AND USES THEREOF

The present invention relates to novel antagonists for CCR2 (CC chemokine receptor 2) and their use for providing medicaments for treating conditions and diseases, especially pulmonary diseases like asthma and COPD.

NOVEL ANTAGONISTS FOR CCR2 AND USES THEREOF

The present invention relates to novel antagonists for CCR2 (CC chemokine receptor 2) of formula (I) and their use for providing medicaments for treating conditions and diseases, especially pulmonary diseases like asthma and COPD.

NOVEL CCR2 RECEPTOR ANTAGONISTS, METHOD FOR PRODUCING THE SAME, AND USE THEREOF AS MEDICAMENTS

The present invention relates to novel antagonists for CCR2 (CC chemokine receptor 2) of formula (I) wherein HET is a group selected from among formulas (IIa) (IIb) (IIc) (IId) and their use for providing medicaments for treating conditions and diseases, especially pulmonary diseases like asthma and COPD and pain diseases.

NEW CCR2 RECEPTOR ANTAGONISTS, METHOD FOR PRODUCING THE SAME, AND USE THEREOF AS MEDICAMENTS

The present invention relates to novel antagonists for CCR2 (CC chemokine receptor 2) and their use for providing medicaments for treating conditions and diseases, especially pulmonary diseases like asthma and COPD and pain diseases

CCR2 ANTAGONISTS AND USES THEREOF

The present invention relates to novel antagonists for CCR2 (CC chemokine receptor 2) and their use for providing medicaments for treating conditions and diseases, especially pulmonary diseases like asthma and COPD.

CCR2 RECEPTOR ANTAGONISTS

The present invention relates to novel antagonists for CCR2 (CC chemokine receptor 2) and their use for providing medicaments for treating conditions and diseases, especially pulmonary diseases like asthma and COPD.

NEW CCR2 RECEPTOR ANTAGONISTS AND USES THEREOF

The present invention relates to novel antagonists for CCR2 (CC chemokine receptor 2) of Formula (I) and their use for providing medicaments for treating conditions and diseases, especially pulmonary diseases like asthma and COPD.

NEW CCR2 ANTAGONISTS

The present invention relates to novel antagonists for CCR2 (CC chemokine receptor 2) of formula (Ia) and their use for providing medicaments for treating conditions and diseases, especially pulmonary diseases like asthma and COPD.

CYCLIC PYRIMIDIN-4-CARBOXAMIDES AS CCR2 RECEPTOR ANTAGONISTS FOR TREATMENT OF INFLAMMATION, ASTHMA AND COPD

The present invention relates to novel antagonists for CCR2 (CC chemokine receptor 2) and their use for providing medicaments for treating conditions and diseases, especially pulmonary diseases like asthma and COPD. Formula (I), wherein A is selected from among a single bond, =CH-, -CH2-, -O-, -S-, and -NH-; wherein n is 1, 2 or 3; wherein Z is C or N, the other variables are as defined in the claims, as well as in form of their acid addition salts with pharmacologically acceptable acids.